ArticleTranslational andrology and urology2025
Histological prostatitis and its influence on benign prostatic hyperplasia: a systematic review and meta-analysis.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dual-center development and external validation of machine learning models integrating PSA-derived and peripheral inflammatory markers for prostate cancer diagnosis.Translational andrology and urology · 2026Article
- Development and explainability of a machine learning prediction model for histological prostatic inflammation in surgically treated patients with benign prostatic hyperplasia: a single-center internal validation study.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammation is considered one of the potential etiological factors in the development and progression of benign prostatic hyperplasia (BPH). However, whether inflammation plays a critical role in the onset or progression of BPH remains controversial. Therefore, we conducted this systematic review and meta-analysis to comprehensively evaluate the impact of histological prostatitis on BPH. Methods: We systematically searched cohort and cross-sectional studies published up to April 2025 in PubMed, the Cochrane Library, Embase, and Web of Science. The quality of the included cohort studies was assessed using the Newcastle-Ottawa Scale (NOS), and cross-sectional studies was evaluated with the Joanna Briggs Institute (JBI) checklist. Data were extracted on prostate volume (PV), International Prostate Symptom Score (IPSS), prostate-specific antigen (PSA), maximum urinary flow rate (Qmax), and residual urine volume (RUV). The effect sizes were pooled using the weighted mean difference (WMD) with corresponding 95% confidence intervals (CIs). Results: A total of 11 studies were included, comprising 6 cohort studies and 5 cross-sectional studies, with a combined sample of 3,135 patients. In cross-sectional studies, compared with patients with BPH alone, those with BPH combined with histological prostatitis had an increase of 1.50 ng/mL in PSA level (95% CI: 0.09 to 2.91; I Conclusions: Histological prostatitis may play a promoting role in the progression of BPH. Compared to patients with BPH alone, those with coexisting histological prostatitis exhibited higher PSA levels, higher IPSS, larger PV, and lower Qmax. Therefore, the clinical significance of histological prostatitis should not be overlooked, and it ought to be considered as an important factor in the clinical management of urological patients. Future large-scale prospective studies are warranted to clarify its role in the pathogenesis of BPH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.